2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine

C88H69N27O8S3 — CID 161163420

IUPAC2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine
SMILESCS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4c(O)cccc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccc(C#N)cc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ncccc4[nH]3)n2)cc1.Nc1ncc(-c2ccccc2)nc1-c1nc2c(O)cccc2[nH]1.Nc1ncc(-c2ccccc2)nc1-c1nc2ccccc2[nH]1
InChIInChI=1S/C19H14N6O2S.C18H15N5O3S.C17H14N6O2S.C17H13N5O.C17H13N5/c1-28(26,27)13-5-3-12(4-6-13)16-10-22-18(21)17(23-16)19-24-14-7-2-11(9-20)8-15(14)25-19;1-27(25,26)11-7-5-10(6-8-11)13-9-20-17(19)16(21-13)18-22-12-3-2-4-14(24)15(12)23-18;1-26(24,25)11-6-4-10(5-7-11)13-9-20-15(18)14(21-13)17-22-12-3-2-8-19-16(12)23-17;18-16-15(17-21-11-7-4-8-13(23)14(11)22-17)20-12(9-19-16)10-5-2-1-3-6-10;18-16-15(17-21-12-8-4-5-9-13(12)22-17)20-14(10-19-16)11-6-2-1-3-7-11/h2-8,10H,1H3,(H2,21,22)(H,24,25);2-9,24H,1H3,(H2,19,20)(H,22,23);2-9H,1H3,(H2,18,20)(H,19,22,23);1-9,23H,(H2,18,19)(H,21,22);1-10H,(H2,18,19)(H,21,22)
InChIKeyUQFIWELKCWTFQC-UHFFFAOYSA-N
MW1728.90 g/mol
LogP13.23
Rot. Bonds13

About 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine

2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine (PubChem CID 161163420) has the molecular formula C88H69N27O8S3 and a molecular weight of 1728.90 g/mol. Its IUPAC name is 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine.

Molecular Properties

Compound Name2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine
PubChem CID161163420
Molecular FormulaC88H69N27O8S3
Molecular Weight1728.90 g/mol
Exact Mass1727.50
IUPAC Name2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine
SMILESCS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4c(O)cccc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccc(C#N)cc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ncccc4[nH]3)n2)cc1.Nc1ncc(-c2ccccc2)nc1-c1nc2c(O)cccc2[nH]1.Nc1ncc(-c2ccccc2)nc1-c1nc2ccccc2[nH]1
InChIInChI=1S/C19H14N6O2S.C18H15N5O3S.C17H14N6O2S.C17H13N5O.C17H13N5/c1-28(26,27)13-5-3-12(4-6-13)16-10-22-18(21)17(23-16)19-24-14-7-2-11(9-20)8-15(14)25-19;1-27(25,26)11-7-5-10(6-8-11)13-9-20-17(19)16(21-13)18-22-12-3-2-4-14(24)15(12)23-18;1-26(24,25)11-6-4-10(5-7-11)13-9-20-15(18)14(21-13)17-22-12-3-2-8-19-16(12)23-17;18-16-15(17-21-11-7-4-8-13(23)14(11)22-17)20-12(9-19-16)10-5-2-1-3-6-10;18-16-15(17-21-12-8-4-5-9-13(12)22-17)20-14(10-19-16)11-6-2-1-3-7-11/h2-8,10H,1H3,(H2,21,22)(H,24,25);2-9,24H,1H3,(H2,19,20)(H,22,23);2-9H,1H3,(H2,18,20)(H,19,22,23);1-9,23H,(H2,18,19)(H,21,22);1-10H,(H2,18,19)(H,21,22)
InChIKeyUQFIWELKCWTFQC-UHFFFAOYSA-N
XLogP13.23
TPSA581.96 Ų
H-Bond Donors12
H-Bond Acceptors30
Rotatable Bonds13
Heavy Atoms126
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001728.90
LogP ≤ 513.23
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1030

Analyze 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine?
The IUPAC name of 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine (CID 161163420) is 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine.
What is the SMILES notation for 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine?
The canonical SMILES for 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine is CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4c(O)cccc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccc(C#N)cc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ncccc4[nH]3)n2)cc1.Nc1ncc(-c2ccccc2)nc1-c1nc2c(O)cccc2[nH]1.Nc1ncc(-c2ccccc2)nc1-c1nc2ccccc2[nH]1.
What is the InChIKey of 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine?
The InChIKey is UQFIWELKCWTFQC-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H14N6O2S.C18H15N5O3S.C17H14N6O2S.C17H13N5O.C17H13N5/c1-28(26,27)13-5-3-12(4-6-13)16-10-22-18(21)17(23-16)19-24-14-7-2-11(9-20)8-15(14)25-19;1-27(25,26)11-7-5-10(6-8-11)13-9-20-17(19)16(21-13)18-22-12-3-2-4-14(24)15(12)23-18;1-26(24,25)11-6-4-10(5-7-11)13-9-20-15(18)14(21-13)17-22-12-3-2-8-19-16(12)23-17;18-16-15(17-21-11-7-4-8-13(23)14(11)22-17)20-12(9-19-16)10-5-2-1-3-6-10;18-16-15(17-21-12-8-4-5-9-13(12)22-17)20-14(10-19-16)11-6-2-1-3-7-11/h2-8,10H,1H3,(H2,21,22)(H,24,25);2-9,24H,1H3,(H2,19,20)(H,22,23);2-9H,1H3,(H2,18,20)(H,19,22,23);1-9,23H,(H2,18,19)(H,21,22);1-10H,(H2,18,19)(H,21,22).
What are the key properties of 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine?
2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine has a molecular weight of 1728.90 g/mol, XLogP of 13.23, 13 rotatable bonds, 12 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine is sourced from PubChem (CID 161163420), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).